Over 60s get long-term protection against RSV from single shot

A three-year study has found robust evidence that one vaccine for respiratory syncytial virus offers older adults long-term protection, even if efficacy wanes. Despite this, just one dose cut serious illness by nearly two thirds across three seasons.

Source of Article

Continue ReadingOver 60s get long-term protection against RSV from single shot

Pain pathway in a dish opens the door to better chronic pain treatments

Tiny 3D organs connected themselves in a lab dish, forming a replica of the human pain pathway, in a new study. The discovery allows scientists to better understand chronic pain and offers an animal-free method of testing pain treatments.

Source of Article

Continue ReadingPain pathway in a dish opens the door to better chronic pain treatments

Deadly flesh-eating infection on the rise in the US and getting harder to kill

A decade-long study of 35 million Americans in 10 states has found that group A streptococcus infections have more than doubled. What's more, "strep" – which can cause a bizarre flesh-eating disease – has become increasingly resistant to antibiotics.

Source of Article

Continue ReadingDeadly flesh-eating infection on the rise in the US and getting harder to kill

Next-gen weight-loss drugs will be here within 12 months

It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks like we'll have the next generation of these breakthrough weight loss and diabetes medicines on shelves by early next year.

Source of Article

Continue ReadingNext-gen weight-loss drugs will be here within 12 months

Paxlovid 2.0: Next generation of COVID antiviral hits final human trials

COVID antiviral Paxlovid wasn't perfect. Many patients couldn't take it due to extreme side effects but now the second generation of antivirals are on the way and they promise better efficacy and fewer drug complications.

Source of Article

Continue ReadingPaxlovid 2.0: Next generation of COVID antiviral hits final human trials

New pill reduces nasty side-effects of Parkinson’s meds in human trial

A mainstay of Parkinson's disease treatment, levodopa can cause nasty side-effects with long-term use. A recent human trial found that a new drug significantly reduces these effects, representing a breakthrough milestone in Parkinson’s treatment.

Source of Article

Continue ReadingNew pill reduces nasty side-effects of Parkinson’s meds in human trial

Gene therapy surgery restores some vision to legally blind children

Scientists in the UK have successfully used gene therapy to restore some vision to legally blind children with an inherited retinal condition. All 11 children in the clinical trial saw improvements within weeks of a single surgical treatment.

Source of Article

Continue ReadingGene therapy surgery restores some vision to legally blind children

Broccoli sprout compound can help fend off type 2 diabetes

An antioxidant found in broccoli sprouts in high concentrations can improve blood sugar levels in people with prediabetes, the precursor to type 2 diabetes, according to new research. The findings suggest a personalized treatment approach is needed.

Source of Article

Continue ReadingBroccoli sprout compound can help fend off type 2 diabetes

PAC-MANN diagnoses early-stage pancreatic cancer with 85% accuracy

Scientists at Oregon Health and Science University (OHSU) have developed a new blood test for pancreatic cancer, one of the most deadly forms of the disease. Tests showed up to 85% accuracy in detection, even in early stages.

Source of Article

Continue ReadingPAC-MANN diagnoses early-stage pancreatic cancer with 85% accuracy